A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Part of paid clinical trials in Chandler, Arizona.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT05869903
- Phase
- PHASE3
- Status
- Active Not Recruiting
Conditions
- Obesity
- Overweight
- Overweight or Obesity
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Orforglipron — DRUGAdministered orally.
- Placebo — DRUGAdministered orally.
Study Details
This study will investigate the efficacy and safety of once daily oral orforglipron in adult participants with obesity or overweight with weight-related comorbidities. The study has two phases: a main phase and an extension phase. The main phase of the study lasted 72 weeks. Participants with prediabetes will continue in the extension for another 2 years.
Key Dates
- Start date
- Jun 5, 2023
- Status verified
- Nov 2025
- Primary completion
- Jul 25, 2025
- Completion
- Oct 31, 2027
Study Design
- Enrollment
- 3,127 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Orforglipron Dose 1Participants will receive orforglipron administered orally.
- Experimental: Orforglipron Dose 2Participants will receive orforglipron administered orally.
- Experimental: Orforglipron Dose 3Participants will receive orforglipron administered orally.
- Placebo Comparator: PlaceboParticipants will be given placebo.
Primary Outcome Measure
Mean Percent Change from Baseline in Body Weight [ Time Frame: Baseline to Week 72 ]
Locations (43)
Related coverage on Hipa.ai
- Orforglipron Phase 3 Trial for Obesity/Overweight Completes Primary PhaseOrforglipron · Jul 25, 2025 · ClinicalTrials.gov
Find similar trials in Chandler, AZ
By condition
By specialty
By research site
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa· Chandler, AZClinical Research Institute of Arizona (CRI) - Sun City West· Sun City West, AZJohn Muir Physician Network Research Center· Concord, CAAMCR Institute· Escondido, CANorCal Medical Research, Inc· Greenbrae, CAVelocity Clinical Research, Huntington Park· Huntington Park, CA
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Physical and Behavioral Traits of Overweight and Obese AdultsRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss TreatmentPHASE2 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Phoenix, Arizona
- Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular SystemRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Washington D.C., District of Columbia